Equities research analysts expect that Integer Holdings Corp (NYSE:ITGR) will announce sales of $292.00 million for the current fiscal quarter, Zacks reports. Two analysts have provided estimates for Integer’s earnings, with estimates ranging from $291.30 million to $292.70 million. Integer reported sales of $363.31 million during the same quarter last year, which indicates a negative year-over-year growth rate of 19.6%. The firm is expected to issue its next quarterly earnings results on Thursday, October 25th.
On average, analysts expect that Integer will report full year sales of $1.24 billion for the current fiscal year, with estimates ranging from $1.20 billion to $1.28 billion. For the next fiscal year, analysts expect that the business will post sales of $1.25 billion per share. Zacks’ sales calculations are a mean average based on a survey of analysts that that provide coverage for Integer.
Integer (NYSE:ITGR) last released its quarterly earnings results on Thursday, August 2nd. The medical equipment provider reported $1.06 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.88 by $0.18. The business had revenue of $313.00 million during the quarter, compared to the consensus estimate of $379.41 million. Integer had a return on equity of 12.60% and a net margin of 6.63%. The firm’s quarterly revenue was up 11.4% on a year-over-year basis. During the same period in the previous year, the company posted $0.62 EPS.
A number of research firms have recently weighed in on ITGR. TheStreet upgraded Integer from a “c+” rating to a “b” rating in a research report on Monday, August 6th. Royal Bank of Canada reiterated a “hold” rating and set a $72.00 target price on shares of Integer in a research report on Friday, August 3rd. Northcoast Research upgraded Integer to a “buy” rating and set a $83.00 target price for the company in a research report on Friday, July 20th. KeyCorp reiterated an “overweight” rating and set a $78.00 target price (up from $65.00) on shares of Integer in a research report on Friday, July 6th. They noted that the move was a valuation call. Finally, Argus began coverage on Integer in a research report on Wednesday, June 27th. They set a “buy” rating and a $78.00 target price for the company. Two analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. Integer has an average rating of “Buy” and a consensus price target of $76.80.
In other news, Director Bill R. Sanford sold 8,650 shares of the company’s stock in a transaction on Wednesday, September 5th. The stock was sold at an average price of $80.10, for a total transaction of $692,865.00. Following the completion of the sale, the director now directly owns 74,502 shares in the company, valued at approximately $5,967,610.20. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, VP Timothy G. Mcevoy sold 21,667 shares of the company’s stock in a transaction on Friday, August 24th. The shares were sold at an average price of $76.93, for a total value of $1,666,842.31. Following the sale, the vice president now owns 40,156 shares of the company’s stock, valued at $3,089,201.08. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 78,889 shares of company stock valued at $5,897,134. Corporate insiders own 3.60% of the company’s stock.
Several hedge funds have recently made changes to their positions in ITGR. Point72 Hong Kong Ltd bought a new stake in shares of Integer during the 2nd quarter worth $111,000. Mount Yale Investment Advisors LLC bought a new stake in shares of Integer during the 1st quarter worth $140,000. Federated Investors Inc. PA lifted its position in shares of Integer by 236.3% during the 2nd quarter. Federated Investors Inc. PA now owns 2,411 shares of the medical equipment provider’s stock worth $156,000 after buying an additional 1,694 shares during the last quarter. BlueMountain Capital Management LLC bought a new stake in shares of Integer during the 2nd quarter worth $194,000. Finally, Verition Fund Management LLC bought a new stake in shares of Integer during the 1st quarter worth $200,000. Institutional investors and hedge funds own 96.18% of the company’s stock.
Shares of NYSE:ITGR traded up $0.05 during trading on Friday, reaching $81.00. 265,000 shares of the company traded hands, compared to its average volume of 214,046. The company has a market cap of $2.58 billion, a price-to-earnings ratio of 28.74 and a beta of 0.83. The company has a debt-to-equity ratio of 1.64, a quick ratio of 2.95 and a current ratio of 3.80. Integer has a 52 week low of $42.50 and a 52 week high of $82.25.
Integer Holdings Corporation operates as a medical device outsource manufacturer worldwide. It operates through two segments, Medical and Non-Medical. The company offers arthroscopic devices and components, such as shaver blades and burrs, ablation probes, and suture anchors; laparoscopic and general surgery products, including trocars, endoscopes and laparoscopes, closure devices, harmonic scalpels, bipolar energy delivery devices, radio frequency probes, thermal tumor ablation devices, and ophthalmic surgery devices; and biopsy and drug delivery products.
Featured Story: Earnings Per Share
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.